跳至主要内容
临床试验/JPRN-UMIN000044337
JPRN-UMIN000044337招募中未知

A prospective randomized study on the incidence of postoperative Proximal junctional fracture(PJF) in patients undergoing spinal deformity surgery according to osteoporosis drugs - A prospective study on PJF incidence according to osteoporosis drugs in patients with spinal deformity

Hamamatsu University School of Medicine0 个研究点目标入组 60 人开始时间: 2021年5月26日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with neuromuscular diseases such as Parkinson's disease 2. Patients with syndromic scoliosis 3. Patients who have undergone surgery for spinal deformity due to infection or tumor. 4. Patients who are deemed inappropriate by the doctor in charge. 5. women who are pregnant or who wish to become pregnant 6. Patients who have already been treated with teriparatide for osteoporosis 7.Patients for whom teriparatide is contraindicated (Paget's disease of bone, unexplained high ALP levels, radiotherapy with possible effect on bone, hyper caemia, metabolic bone diseases other than osteoporosis) 8.Patients with contraindications to bisphosphonates (severe renal failure, esophageal achalasia, hypocalcemia, hypersensitivity to bisphosphonates) 9. Patients who have received Denosumab subcutaneous injection 60 mg within 6 months of obtaining consent, or Zoledronic Acid Hydrate intravenous solution 5 mg within 1 year of obtaining consent.

研究者

相似试验